Overview
Health Technology Assessment processes have recently been introduced in a number of countries to facilitate health care decision making on reimbursement of both drugs and medical devices. This worldwide trend has highlighted a need to recognise the main characteristics of HTA and distinguish it from other evaluation processes. Similarly, the differences in product development and the regulatory framework for market access between medical devices and drugs have been perceived as an obstacle to conduct HTA in medical devices. In this tutorial we will describe both:
- key components of a HTA process
- a framework to facilitate the implementation of HTA process of drugs and medical devices
Who Should Attend
Individuals who in different capacities contribute to the preparation and submission of health technology dossiers to HTA regulatory agencies such as the National Institute for Health and Clinical Excellence, (NICE), UK
Learning Objectives
At the conclusion of this tutorial, attendees will be able to:
- Recognise the distinction between key concepts in HTA (e.g. evidence base medicine, clinical effectiveness and health technology assessment)
- Describe the necessary steps involved in a HTA process
- Understand the iterative nature of HTA processes
- Identify the way in which differences in product development and market access regulation impacts on HTA processes of drugs and pharmaceuticals